Improve Screening Criteria for Retinopathy of Prematurity in Two French Center - Trial NCT05152862
Access comprehensive clinical trial information for NCT05152862 through Pure Global AI's free database. This phase not specified trial is sponsored by Centre Hospitalier Sud Francilien and is currently Completed. The study focuses on Retinopathy of Prematurity. Target enrollment is 886 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Centre Hospitalier Sud Francilien
Timeline & Enrollment
N/A
Mar 21, 2022
Jun 16, 2022
Primary Outcome
Number of infants with type 1 or 2 ROP found at routine screening.
Summary
The aim of the study is to assess whether a delay of the first examination can be safely
 considered in French population. Secondary objectives are to describe retinopathy of
 prematurity (ROP) in a population of premature from two French tertiary NICU and to identify
 co-morbidities associated with the development of severe ROP.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05152862
Non-Device Trial